Developing a Lifestyle Intervention for South Asians

Sponsor
Emory University (Other)
Overall Status
Completed
CT.gov ID
NCT03861546
Collaborator
(none)
14
1
1
3.7
3.8

Study Details

Study Description

Brief Summary

This study aims to test the hypothesis that a culturally tailored lifestyle intervention can improve health behaviors among South Asians with prediabetes and diabetes

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Healthy lifestyle Shared Medical Appointment (SMA) program
N/A

Detailed Description

This pre-post pilot study is a 16 week lifestyle program for South Asians with prediabetes or diabetes in Atlanta. Patients will participate in physician-led group visits every other week focused on improving dietary and exercise practices to reduce weight.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Better Together: Leveraging Primary Care and Social Network Resources to Create a Patient-centered Approach to Improve Diabetes Among South Asians
Actual Study Start Date :
Mar 3, 2019
Actual Primary Completion Date :
Jun 23, 2019
Actual Study Completion Date :
Jun 23, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy lifestyle Shared Medical Appointment (SMA) program

South Asian (SA) adults with prediabetes and Type 2 Diabetes (T2D) that are 'information rich' and have variation in background characteristics will be identified. Dyads (spouses, parent/adolescent or young adult child, peers) will participate in a 16-week culturally-tailored, community-informed pre-post SMA intervention to improve health behaviors.

Behavioral: Healthy lifestyle Shared Medical Appointment (SMA) program
Social network-based, culturally-tailored healthy lifestyle SMA program for high risk SAs will be piloted to collect pre-post data on diet and exercise habits, and to determine feasibility and acceptability. Patients will participate in physician-led group visits every other week focused on improving dietary and exercise practices to reduce weight. Biometric measurements (weight, height, blood pressure) will be collected, point of care glucose and lipid testing will be done.

Outcome Measures

Primary Outcome Measures

  1. Participant perceptions of SMA program [4 months]

    Physician-participants interviews will be digitally audio-recorded and transcribed verbatim, with de-identified transcripts analyzed.

  2. SMA program retention rate [4 months]

    Number of participants retained will be recorded and SMA retention rate will be calculated

Secondary Outcome Measures

  1. Change in body mass index (BMI) [Baseline, 4 months, and 12 months]

    Body Mass Index (BMI) is a number representing person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness.

  2. Change in blood pressure [Baseline, 4 months, and 12 months]

    Blood pressure will be measured pre- and post- intervention

  3. Change in blood cholesterol level [Baseline, 4 months, and 12 months]

    Cholesterol level will be measured by blood test pre- and post- intervention

  4. Change in physical activity daily minutes [Baseline, 4 months, and 12 months]

    Daily minutes of moderate intensity exercise will be self reported by participants

  5. Change in step counts [Baseline, 4 months, and 12 months]

    Daily step counts (using wearable perdometer) will be recorded.

  6. Change in diet [Baseline, 4 months, and 12 months]

    Pre-post assessment of change in consumption will be done using food frequency questionnaire. It has 16 questions that assess dietary habits over the past week.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. age > 18 years;

  2. confirmed diagnosis of prediabetes or T2D (documented A1c of ≥ 5.7%, 2-hour post-load glucose of >140, or FBG of >100);

  3. a family member or peer willing to participate and attend all sessions as a social influencer;

  4. proficiency in English of at least one member of each dyad,

  5. willingness to provide written consent.

Exclusion Criteria:
  1. type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced);

  2. malignancy or life-threatening illness with life expectancy of <5 years;

  3. end-stage disease or serious illness that prohibits participation (e.g. end-stage renal disease or class IV congestive heart failure);

  4. inability to perform unsupervised physical activity;

  5. pregnancy;

  6. diagnosed cognitive deficits or limited decision-making capacity;

  7. alcohol or substance abuse;

  8. homelessness or no fixed address.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emory Family Medicine Clinic Atlanta Georgia United States 30322

Sponsors and Collaborators

  • Emory University

Investigators

  • Principal Investigator: Megha K Shah, MD, Emory University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Megha Kumudchandra Shah, Principal Investigator, Emory University
ClinicalTrials.gov Identifier:
NCT03861546
Other Study ID Numbers:
  • IRB00097724
First Posted:
Mar 4, 2019
Last Update Posted:
Nov 18, 2019
Last Verified:
Nov 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Megha Kumudchandra Shah, Principal Investigator, Emory University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2019